Skip to content
Recall Observatory FDA recall evidence

Drug product

Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 90-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-447-15

D-0518-2025

June 20, 2025

Class II

Product summary

Firm
ACCORD HEALTHCARE, INC.
Event
Event 97103
Status
Ongoing
Classification
Class II
Quantity
82,159 bottles
Official record key
drug-enforcement:D-0518-2025

Official wording

Reason: Subpotent Drug: Assay below the approved specification

Code information: Lot #D2300325, Exp Date: 01/31/2026; Lot #D2400536, Exp Date: 02/28/2026

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent